T P McVeigh1,2, K J Sweeney3, M J Kerin4, D J Gallagher5,6. 1. Department of Clinical Genetics, Our Lady's Children's Hospital Crumlin, Dublin 12, Ireland. terri.mcveigh@gmail.com. 2. National University of Ireland, Galway, Ireland. terri.mcveigh@gmail.com. 3. BreastCheck, Western Unit, Galway University Hospital, Galway, Ireland. 4. National University of Ireland, Galway, Ireland. 5. Mater Misericordiae University Hospital, Dublin, Ireland. 6. St James' University Hospital, Dublin, Ireland.
Abstract
BACKGROUND: Progress in diagnostic and therapeutic strategies in medicine is dependent upon high-quality biomedical research. Technological advances have facilitated improved understanding of disease aetiology, and rapidly emerging data promises further progress. Translating this potential into the clinic depends on patient participation in innovative clinical trials. We investigated attitudes to genetic research in Ireland, particularly with respect to commercial and financial implications. METHODS: A multi-centre, cross-sectional survey study was performed. Consecutive out-patients attending four clinics were asked to complete paper-based questionnaires. The same questionnaire was publicly available in electronic format on www.surveymonkey.com for 72 h. Data were analysed using SPSS. RESULTS: 351 questionnaires were completed (99 paper, 252 electronic). The majority of respondents were female (n = 288, 82 %), and highly educated, with 244 (70 %) attending college/university. Most participants supported genetic research (267, 76 %), more frequently for common diseases (274, 78 %) than rare disorders (204, 58 %, p < 0.001, χ 2). 103 (29 %) had participated in scientific research, and 57 (16 %) had donated material to a bio-bank. The majority (n = 213, 61 %) would not support research with potential financial/commercial gain. 106 (30 %) would decline to participate in research if researchers would benefit financially, compared to 49 (14 %) if the research was supported by a pharmaceutical company (p < 0.001, χ 2). Respondents would provide buccal samples (258, 74 %) more readily than tissue (225, 64 %) or blood (222, 63 %). CONCLUSIONS: A high level of support for genetic research exists among the Irish population, but active participation is dependent upon a number of factors, notably, type of biological material required, frequency of the disease in question, and commercial interest of the researchers.
BACKGROUND: Progress in diagnostic and therapeutic strategies in medicine is dependent upon high-quality biomedical research. Technological advances have facilitated improved understanding of disease aetiology, and rapidly emerging data promises further progress. Translating this potential into the clinic depends on patient participation in innovative clinical trials. We investigated attitudes to genetic research in Ireland, particularly with respect to commercial and financial implications. METHODS: A multi-centre, cross-sectional survey study was performed. Consecutive out-patients attending four clinics were asked to complete paper-based questionnaires. The same questionnaire was publicly available in electronic format on www.surveymonkey.com for 72 h. Data were analysed using SPSS. RESULTS: 351 questionnaires were completed (99 paper, 252 electronic). The majority of respondents were female (n = 288, 82 %), and highly educated, with 244 (70 %) attending college/university. Most participants supported genetic research (267, 76 %), more frequently for common diseases (274, 78 %) than rare disorders (204, 58 %, p < 0.001, χ 2). 103 (29 %) had participated in scientific research, and 57 (16 %) had donated material to a bio-bank. The majority (n = 213, 61 %) would not support research with potential financial/commercial gain. 106 (30 %) would decline to participate in research if researchers would benefit financially, compared to 49 (14 %) if the research was supported by a pharmaceutical company (p < 0.001, χ 2). Respondents would provide buccal samples (258, 74 %) more readily than tissue (225, 64 %) or blood (222, 63 %). CONCLUSIONS: A high level of support for genetic research exists among the Irish population, but active participation is dependent upon a number of factors, notably, type of biological material required, frequency of the disease in question, and commercial interest of the researchers.
Entities:
Keywords:
Biobank; Biological specimen; Biomedical research; Data protection; Genetic research
Authors: Amy L McGuire; Jill Oliver Robinson; Rachel B Ramoni; Debra S Morley; Steven Jofe; Sharon E Plon Journal: Per Med Date: 2013-01 Impact factor: 2.512
Authors: C Royal; A Baffoe-Bonnie; R Kittles; I Powell; J Bennett; G Hoke; C Pettaway; S Weinrich; S Vijayakumar; C Ahaghotu; T Mason; E Johnson; M Obeikwe; C Simpson; R Mejia; W Boykin; P Roberson; J Frost; L Faison-Smith; C Meegan; N Foster; P Furbert-Harris; J Carpten; J Bailey-Wilson; J Trent; K Berg; G Dunston; F Collins Journal: Ann Epidemiol Date: 2000-11 Impact factor: 3.797
Authors: Cristina Sánchez-Mora; Josep A Ramos-Quiroga; Rosa Bosch; Montse Corrales; Iris Garcia-Martínez; Mariana Nogueira; Mireia Pagerols; Gloria Palomar; Vanesa Richarte; Raquel Vidal; Alejandro Arias-Vasquez; Mariona Bustamante; Joan Forns; Silke Gross-Lesch; Monica Guxens; Anke Hinney; Martine Hoogman; Christian Jacob; Kaya K Jacobsen; Cornelis C Kan; Lambertus Kiemeney; Sarah Kittel-Schneider; Marieke Klein; Marten Onnink; Olga Rivero; Tetyana Zayats; Jan Buitelaar; Stephen V Faraone; Barbara Franke; Jan Haavik; Stefan Johansson; Klaus-Peter Lesch; Andreas Reif; Jordi Sunyer; Mònica Bayés; Miguel Casas; Bru Cormand; Marta Ribasés Journal: Neuropsychopharmacology Date: 2014-10-06 Impact factor: 7.853
Authors: Isabella Fogh; Antonia Ratti; Cinzia Gellera; Kuang Lin; Cinzia Tiloca; Valentina Moskvina; Lucia Corrado; Gianni Sorarù; Cristina Cereda; Stefania Corti; Davide Gentilini; Daniela Calini; Barbara Castellotti; Letizia Mazzini; Giorgia Querin; Stella Gagliardi; Roberto Del Bo; Francesca L Conforti; Gabriele Siciliano; Maurizio Inghilleri; Francesco Saccà; Paolo Bongioanni; Silvana Penco; Massimo Corbo; Sandro Sorbi; Massimiliano Filosto; Alessandra Ferlini; Anna M Di Blasio; Stefano Signorini; Aleksey Shatunov; Ashley Jones; Pamela J Shaw; Karen E Morrison; Anne E Farmer; Philip Van Damme; Wim Robberecht; Adriano Chiò; Bryan J Traynor; Michael Sendtner; Judith Melki; Vincent Meininger; Orla Hardiman; Peter M Andersen; Nigel P Leigh; Jonathan D Glass; Daniel Overste; Frank P Diekstra; Jan H Veldink; Michael A van Es; Christopher E Shaw; Michael E Weale; Cathryn M Lewis; Julie Williams; Robert H Brown; John E Landers; Nicola Ticozzi; Mauro Ceroni; Elena Pegoraro; Giacomo P Comi; Sandra D'Alfonso; Leonard H van den Berg; Franco Taroni; Ammar Al-Chalabi; John Powell; Vincenzo Silani Journal: Hum Mol Genet Date: 2013-11-20 Impact factor: 6.150
Authors: Kevin Litchfield; Razvan Sultana; Anthony Renwick; Darshna Dudakia; Sheila Seal; Emma Ramsay; Silvana Powell; Anna Elliott; Margaret Warren-Perry; Rosalind Eeles; Julian Peto; Zsofia Kote-Jarai; Kenneth Muir; Jeremie Nsengimana; Michael R Stratton; Douglas F Easton; D Timothy Bishop; Robert A Huddart; Nazneen Rahman; Clare Turnbull Journal: Hum Mol Genet Date: 2014-10-03 Impact factor: 6.150
Authors: Christopher W Medway; Samer Abdul-Hay; Tynickwa Mims; Li Ma; Gina Bisceglio; Fanggeng Zou; Shane Pankratz; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Joanna Siuda; Zbigniew K Wszolek; Owen A Ross; Minerva Carrasquillo; Dennis W Dickson; Neill Graff-Radford; Ronald C Petersen; Nilüfer Ertekin-Taner; Kevin Morgan; Guojun Bu; Steven G Younkin Journal: Mol Neurodegener Date: 2014-03-10 Impact factor: 14.195
Authors: Matthew J Westbrook; M Frances Wright; Sara L Van Driest; Tracy L McGregor; Joshua C Denny; Rebecca L Zuvich; Ellen Wright Clayton; Kyle B Brothers Journal: Genet Med Date: 2012-11-29 Impact factor: 8.822
Authors: Danya F Vears; Joel T Minion; Stephanie J Roberts; James Cummings; Mavis Machirori; Mwenza Blell; Isabelle Budin-Ljøsne; Lorraine Cowley; Stephanie O M Dyke; Clara Gaff; Robert Green; Alison Hall; Amber L Johns; Bartha M Knoppers; Stephanie Mulrine; Christine Patch; Eva Winkler; Madeleine J Murtagh Journal: PLoS One Date: 2021-11-08 Impact factor: 3.240
Authors: Terri Patricia McVeigh; Karl J Sweeney; Donal J Brennan; Una M McVeigh; Simon Ward; Ann Strydom; Sheila Seal; Katherine Astbury; Paul Donnellan; Joanne Higgins; Maccon Keane; Michael J Kerin; Carmel Malone; Pauline McGough; Ray McLaughlin; Michael O'Leary; Margaret Rushe; Michael Kevin Barry; Geraldine MacGregor; Michael Sugrue; Ala Yousif; Dhafir Al-Azawi; Eileen Berkeley; Terence J Boyle; Elizabeth M Connolly; Carmel Nolan; Elaine Richardson; Claire Giffney; Samantha B Doyle; Sheila Broderick; William Boyd; Ruaidhri McVey; Thomas Walsh; Michael Farrell; David J Gallagher; Nazneen Rahman; Angela J George Journal: Fam Cancer Date: 2022-08-27 Impact factor: 2.446
Authors: Davinia S Seah; Nabihah Tayob; Jose Pablo Leone; Jiani Hu; Jun Yin; Melissa Hughes; Sarah M Scott; Ruth I Lederman; Elizabeth Frank; Jessica J Sohl; Zsofia K Stadler; Timothy K Erick; Jeffrey Peppercorn; Eric P Winer; Stuart G Silverman; Steven E Come; Nancy U Lin Journal: Breast Cancer Res Treat Date: 2022-01-23 Impact factor: 4.872